Autonomous Maturation of α/β T Lineage Cells in the Absence of Cooh-Terminal Src Kinase (Csk) by Schmedt, Christian & Tarakhovsky, Alexander
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2001/04/815/11 $5.00
Volume 193, Number 7, April 2, 2001 815–825
http://www.jem.org/cgi/content/full/193/7/815
 
815
 
Autonomous Maturation of 
 
a
 
/
 
b 
 
T Lineage Cells in the 
Absence of COOH-terminal Src Kinase (Csk)
 
By Christian Schmedt and Alexander Tarakhovsky
 
From the Laboratory for Lymphocyte Signaling, The Rockefeller University, New York, New York 
10021; and the Laboratory for Lymphocyte Signaling, Institute for Genetics, University of Cologne, 
50931 Cologne, Germany
 
Abstract
 
The deletion of COOH-terminal Src kinase (Csk), a negative regulator of Src family protein
tyrosine kinases (PTKs), in immature thymocytes results in the development of 
 
a
 
/
 
b 
 
T lineage
cells in T cell receptor (TCR) 
 
b
 
-deficient or recombination activating gene (
 
rag
 
)
 
-1
 
–deficient
mice. The function of Csk as a repressor of Lck and Fyn activity suggests activation of these
PTKs is solely responsible for the phenotype observed in 
 
csk
 
-deficient T lineage cells. We pro-
vide genetic evidence for this notion as 
 
a
 
/
 
b 
 
T cell development is blocked in 
 
lck
 
2
 
/
 
2
 
fyn
 
2
 
/
 
2
 
 
 
csk
 
-
deficient mice. It remains unclear whether activation of Lck and Fyn in the absence of Csk un-
couples 
 
a
 
/
 
b 
 
T cell development entirely from engagement of surface-expressed receptors. We
show that in mice expressing the 
 
a
 
/
 
b 
 
TCR on 
 
csk
 
-deficient thymocytes, positive selection is
biased towards the CD4 lineage and does not require the presence of major histocompatibility
complex (MHC) class I and II. Furthermore, the introduction of an MHC class I–restricted
transgenic TCR into a 
 
csk
 
-deficient background results in the development of mainly CD4 T
cells carrying the transgenic TCR both in selecting and nonselecting MHC background. Thus,
TCR–MHC interactions have no impact on positive selection and commitment to the CD4
lineage in the absence of Csk. However, TCR-mediated negative selection of 
 
csk
 
-deficient,
TCR transgenic cells is normal. These data suggest a differential involvement of the Csk-medi-
ated regulation of Src family PTKs in positive and negative selection of developing thymocytes.
Key words: thymocyte development • thymic selection • conditional gene targeting • T cell 
receptor • Src family kinases
 
Introduction
 
The normal development of 
 
a
 
/
 
b 
 
T cells is controlled by
signals originating from the pre-TCR, TCR, and corecep-
tors CD4 and CD8. Pre-TCR–derived signals are neces-
sary for the progression from CD4
 
2
 
CD8
 
2
 
 double-negative
(DN)
 
1
 
 to CD4
 
1
 
CD8
 
1
 
 double-positive (DP) thymocytes
(for a review, see reference 1). Signaling from the TCR
and coreceptors are required for the complex maturation of
DP thymocytes into CD4
 
1
 
 or CD8
 
1
 
 single-positive (SP)
cells (for reviews, see references 2 and 3). TCRs and CD4
or CD8 coreceptors on DP thymocytes interact with
MHC/peptide complexes present on thymic stromal cells.
If this interaction is of sufficient avidity, the DP cells re-
ceive a survival signal and are positively selected to proceed
in development to the SP stage. In the case of too strong
MHC/peptide–TCR interaction, the cells are negatively
selected and die by apoptosis, similar to those DP cells
which receive no survival signal for lack of MHC/peptide–
TCR interaction (for a review, see reference 3). Positive
selection is accompanied by the commitment to either the
CD4 or CD8 lineage of T cells. The outcome of lineage
commitment and positive selection is coordinated, as usu-
ally CD4 SP thymocytes are self-MHC class II restricted,
whereas CD8 SP thymocytes are restricted to self-MHC
class I molecules. Consequently, mice, which cannot ex-
press MHC class I, MHC class II, or both MHC class I and
class II molecules, lack CD8 T cells, CD4 T cells, or both
CD4 plus CD8 T cells, respectively (4–9).
The first biochemical changes detectable upon TCR en-
 
gagement are the activation of the Src family protein
tyrosine kinases (PTKs) Lck and Fyn, which physically as-
sociate with CD4/CD8 coreceptors and the TCR, respec-
tively (10–12). The combined deletion of 
 
lck
 
 and 
 
fyn
 
 genes,
as well as the overexpression of a dominant negative 
 
lck
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rag
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transgene in mice result in the arrest of thymocyte matura-
tion at the DN stage of development (13–15). Conversely,
expression of constitutively active Lck or Fyn drives re-
combination activating gene (
 
rag
 
)-deficient DN thy-
mocytes to mature to the DP stage of development, and
activated Lck is implicated in mediating allelic exclusion at
the TCR 
 
b
 
 locus (14, 16, 17). Hence, Lck and Fyn are in-
volved at least in the early steps of 
 
a
 
/
 
b 
 
T cell developmen-
tal leading to the generation of DP thymocytes. It is un-
known whether the activation of Lck and Fyn in the
presence of TCR and coreceptors is sufficient to generate
all signals required for the complete developmental pro-
gram of thymocyte maturation.
To investigate if Src family PTKs are involved in all steps
of 
 
a
 
/
 
b 
 
T cell development, we took the approach of con-
ditional inactivation of the negative regulator of Src family
PTKs (COOH-terminal Src kinase [Csk]) during 
 
a
 
/
 
b 
 
T
cell development. We previously showed that 
 
a
 
/
 
b 
 
T cells
can develop from csk-deficient DN thymocytes in the ab-
sence of pre-TCR and 
 
a
 
/
 
b 
 
TCR (18). This TCR-inde-
pendent T cell maturation passes through all stages of thy-
mocyte development and is accompanied by an increase in
the specific activity of Lck and Fyn in 
 
csk
 
-deficient thy-
mocytes. From our previous analysis, it remained unclear
whether 
 
g
 
/
 
d 
 
TCR–derived signals contribute to the 
 
a
 
/
 
b
 
TCR–independent generation of T cells. Furthermore,
Csk substrates other than Lck and Fyn could be responsible
for the autonomous T cells maturation. Finally, it is un-
known whether the deletion of 
 
csk
 
 in thymocytes that ex-
press a TCR causes an uncoupling of TCR engagement
from thymocyte maturation, or if TCR-derived signals
dominate over the activation of Lck and Fyn caused by the
absence of Csk.
Here we provide evidence that 
 
a
 
/
 
b 
 
T cell development
in the absence of Csk is also independent of 
 
g
 
/
 
d 
 
TCR ex-
pression and that no other substrate of Csk is sufficient to
drive T cell development in the absence of Lck and Fyn.
Furthermore, we show that the positive selection of 
 
csk
 
-
deficient thymocytes is largely uncoupled from TCR-derived
input on the developmental fate, whereas TCR-mediated
negative selection appears normal in the absence of Csk.
 
Materials and Methods
 
Mice.
 
All mice used in these experiments were maintained in
a conventional animal facility and analyzed at 6–8 wk of age.
Maintenance and analysis of mice were done according to the
German animal protection law. The generation of 
 
csk
 
fl/fl
 
 mice has
been described (18). 
 
Csk
 
fl/fl
 
lck-cre
 
, 
 
csk
 
fl/fl
 
rag-1
 
2
 
/
 
2
 
MX-cre
 
 
 
csk
 
fl/fl
 
b
 
2m
 
2
 
/
 
2
 
A
 
a
 
2
 
/
 
2
 
lck-cre
 
, and
 
 csk
 
fl/fl
 
lck-creHY-TCRtg 
 
mice are on
mixed genetic background of 129, CB.20, and C57Bl/6. 
 
csk
 
fl/fl
 
lck-
creHY-TCRtg
 
 mice were bred onto H-2
 
b
 
 or H-2
 
d
 
 MHC back-
ground. 
 
MX-cre
 
 mice were provided by R. Kühn and K. Rajew-
sky (University of Cologne, Cologne, Germany). 
 
Lck-cre
 
 mice
were provided by J. Marth (University of California San Diego,
San Diego, CA). 
 
A
 
a
 
2
 
/
 
2
 
 and 
 
b
 
2m
 
2
 
/
 
2
 
 mice on C57Bl/6 genetic
background were provided by H. Bluethmann and H.J. Fehling
(Roche, Basel, Switzerland), respectively. 
 
rag-1
 
2
 
/
 
2
 
 mice on
C57Bl/6 genetic background were obtained from The Jackson
 
Laboratory. 
 
Lck
 
2
 
/
 
2
 
 mice on C57Bl/6 genetic background and
 
fyn
 
2
 
/
 
2
 
 mice were provided by T. Mak (Amgen, Toronto, Can-
ada) and R. Perlmutter (Merck, Rahway, NJ), respectively.
 
Flow Cytometric Analysis.
 
Mice were killed with CO
 
2
 
 and
lymphoid organs removed. Single cell suspensions were prepared
by gentle tearing of spleens, lymph nodes, or thymi in RPMI
1640 (GIBCO BRL) containing 10% FCS (Roche). When nec-
essary, erythrocytes were lysed by incubating cells in red blood
cell lysis buffer (0.75% NH
 
4
 
Cl, 100 mM Tris/HCl, pH 7.65) for
2–4 min at room temperature. Lysis was stopped by adding 10 ml
of compete RPMI.
Fluorescence staining was performed as described (19). In
brief, 1–2 
 
3
 
 10
 
6
 
 cells were washed in PBS/1% BSA/0.01% so-
dium azide (PBA) and incubated with biotinylated antibodies at
saturating concentrations in PBA for 20 min at 4
 
8
 
C. After wash-
ing with PBA, cells were incubated in PBA containing fluoro-
chrome-conjugated antibodies and streptavidin for 20 min at
4
 
8
 
C. After a final washing step, cells were resuspended in 100–
300 
 
m
 
l PBA and analyzed on a FACSCalibur™ flow cytometer
(Becton Dickinson). For the exclusion of dead cells during analy-
sis, propidium iodide (PI; 0.2 
 
m
 
g/ml; Molecular Probes) or TO-
PRO-3 (1 nM; Molecular Probes) was added to the cells before
acquisition. The following reagents were purchased from BD
PharMingen: CD3
 
e
 
 (145-2C11), CD4 (RM4-5), CD5 (53-7.3),
CD8
 
a
 
 (53-6.7), CD24/HSA (M1/69), CD25 (7D4), CD69
(H1.2F3), CD90/Thy1.2 (53-2.1), TCR 
 
b
 
 (H57-597), and
streptavidin-cychrome. Streptavidin-Cy7–PE was purchased
from Medac. Biotinylated T3.70 and FITC-coupled F23.1 anti-
bodies were gifts from H. von Boehmer (Dana-Farber, Boston,
MA). Antibodies against B220 and Mac-1 were produced at the
Institute for Genetics (Cologne, Germany).
 
Cell Sorting.
 
CD4 T cells were purified by MACS depletion
with anti-CD8, anti-B220, and anti–Mac-1 antibodies according
to the manufacturer’s instructions (Miltenyi Biotec), followed by
FACS
 
®
 
-assisted enrichment of CD4
 
hi
 
 and CD4
 
lo
 
 cells on a FAC-
Star™ (Becton Dickinson) with anti-CD4 and anti-CD8 anti-
bodies. The purity of sorted cells was 
 
.
 
95%.
 
Southern Blotting.
 
Genomic DNA was isolated from 10
 
6
 
–10
 
7
 
cells in suspension following the protocol by Laird et al. (20), fol-
lowed by phenol/chloroform extraction. Southern blot analysis
was done by standard procedures (21). Genomic DNA was di-
gested with EcoRI, size fractionated on 0.7% agarose gels, and
blotted onto nitrocellulose membranes (Geenscreen; NEN Life
Science Products) by capillary transfer. 
 
Csk
 
-specific fragments
were detected with the radiolabeled probe C (18).
Results
TCR-independent Development of T Lineage Cells in the Ab-
sence of Csk. We have previously shown the TCR-inde-
pendent development of csk-deficient a/b T lineage cells in
cskfl/flTCRb2/2MX-cre mice. As these mice can express g/d
TCR, we wanted to exclude a possible involvement of g/d
TCR–derived signaling in the observed phenotype. Mice
were generated to carry homozygous null mutation for rag-1
in combination with two loxP-flanked csk alleles and the
MX-cre transgene (cskfl/flrag-12/2MX-cre; references 18, 22,
and 23). The MX-cre transgene is interferon inducible, but
shows basal activity which results in the expression of Cre
in a small fraction of all thymocyte populations including
DN cells, as determined by Southern blot analysis of Cre-
mediated deletion of a single loxP-flanked csk allele in these817 Schmedt and Tarakhovsky
cells (18). Thymi of Cskfl/flrag-12/2MX-cre mice without
injection of interferon are z10-fold larger than thymi of
rag-12/2 mice and close to the size of control thymi of cskfl/fl
rag-11/2 mice (Fig. 1 A). Southern blot analysis of total thy-
mocyte genomic DNA provides evidence that the thymus
of cskfl/flrag-12/2MX-cre mice consists of exclusively csk-defi-
cient cells (Fig. 1 B). The analysis of csk-deficient thy-
mocytes reveals the presence of DP and CD4-SP cells. The
fraction of DP thymocytes is slightly decreased and the per-
centage of CD4-SP cells is increased compared with cskfl/fl-
rag-11/2 control mice. The analysis of thymocyte matura-
tion markers on DP and CD4-SP cells of cskfl/flrag-12/2MX-
cre mice shows increases in CD69 and CD5 surface expres-
sion on CD4-SP cells as signs of positive selection and also
decreased CD24/HSA surface expression on CD4-SP cells,
which indicates further thymocyte maturation (Fig. 1 C).
The fraction of CD4-SP cells as well as CD691HSAlo cells
is increased in cskfl/flrag-12/2MX-cre mice compared with
cskfl/flrag-11/2 control mice (Fig. 1, A and D). CD8-SP cells
are largely absent in cskfl/flrag-12/2MX-cre mice. Surface ex-
pression levels of CD4 on DP and CD4-SP thymocytes are
reduced in cskfl/flrag-12/2MX-cre mice, compared with simi-
lar cells of control mice (Fig. 1 A). These csk-deficient cells
leave the thymus to form a sizeable peripheral compartment
of CD4lo cells in the spleen and lymph nodes (Fig. 1 D, and
data not shown). Surface expression of CD90/Thy1 and
CD5 suggests the T lineage identity of these CD4lo cells
(Fig. 1 D, and data not shown).
Development of TCR-bearing T Cells in the Absence of
Csk. Considering that T lineage development from csk-
deficient thymocytes is possible without any TCR, the
question arises whether the TCR can at all influence the
fate of csk-deficient thymocytes. To address this issue, T
lineage development in cskfl/fllck-cre mice was analyzed. In
these mice, the cre-transgene is under the control of the
proximal lck promoter. As expected from earlier studies
(24, 25), this promoter limits Cre expression and csk dele-
tion to DN and DP thymocytes (data not shown). The
numbers of thymocytes and splenic T cells in cskfl/fllck-cre
mice are comparable to cskfl/fl control mice (Table I). Anal-
ysis of thymocyte subpopulations in cskfl/fllck-cre mice re-
veals that the percentages of DP and CD8-SP cells are
slightly reduced, whereas CD4-SP and DN fractions are
about twofold increased compared with thymi of cskfl/fl
control mice (Table I, and Fig. 2 A, top). Changes in the
expression of thymocyte maturation markers CD69, CD5,
and CD24/HSA are similar to those described for cskfl/flrag-
12/2MX-cre mice (data not shown). A skewing of the
CD4/CD8 cell ratio is also apparent in peripheral T cells of
cskfl/fllck-cre mice, which have strongly reduced numbers of
CD8 T cells (Fig. 2 A, bottom, and data not shown).
The analysis of TCR surface expression on a/b T lin-
eage cells in cskfl/fllck-cre mice reveals a small population of
CD4loTCR2 cells present in cskfl/fllck-cre mice (Table I and
Fig. 2 B). These cells are likely to be descendents of DN
thymocytes that acquired the csk deletion before a success-
ful rearrangement of their TCR b genes. Overexpression
of an Lck transgene expressed in DN thymocytes has been
reported to mediate allelic exclusion at the TCR b locus
(17). The activation of Lck as a consequence of csk deletion
in DN thymocytes is expected to act similarly and therefore
suppress TCR b gene rearrangements. Hence, similar
to cskfl/flTCRb2/2MX-cre and cskfl/flrag-12/2MX-cre mice,
TCR-deficient cells develop in cskfl/fllck-cre mice.
Figure 1. Positive selection and a peripheral pool of TCR-deficient
T lineage cells in the absence of Csk. (A) FACS® analysis of surface ex-
pression of CD4, CD8, on thymocytes isolated from control and cskfl/fl
rag-12/2MX-cre mice, as indicated. Numbers show percentages of live-
gated cells. Total thymocyte numbers were 17 3 107 for cskfl/flrag-11/2,
0.06 3 107 for rag-12/2, and 6.3 3 107 for cskfl/flrag-12/2MX-cre mice.
Representative data of three independent experiments are shown. (B)
Southern blot analysis of genomic DNA isolated from total thymocytes
of control and cskfl/flrag-12/2MX-cre mice, as indicated. For Southern
blotting, DNA was digested with EcoRI and hybridized with a probe,
which allows to distinguish wild-type, loxP-flanked (fl), and deleted (D)
csk alleles. (C) Histograms show the surface expression of thymocyte
maturation markers based on three-color FACS® analysis, as indicated.
DP (thin line) and CD4-SP (thick line) cells were gated as shown in A.
Staining controls are shown as shaded area in all histograms. (D) FACS®
analysis of surface expression of CD4, CD8, and CD90/Thy-1 on sple-
nocytes isolated from control and cskfl/flrag-12/2MX-cre mice, as indi-
cated. Numbers show percentages of live-gated cells. The total number
of CD4 T cells were 11.3 3 107 and 2.8 3 107 for cskfl/flrag-11/2 and
cskfl/flrag-12/2MX-cre mice, respectively.818 Autonomous T Cell Maturation in the Absence of Csk
CD4 expression is reduced on thymocytes and peripheral
CD4 T cells of cskfl/fllck-cre mice, similar to cskfl/flrag-12/2
MX-cre mice (Fig. 2 A). Also, CD8 expression levels are
reduced on the remaining peripheral CD8 T cells (Fig. 2
A). Surface expression levels of TCR on the majority of
CD4-SP thymocytes and CD4 T cells is three- to fourfold
reduced compared with cskfl/fl control cells (Fig. 2 B). The
Southern blot analysis of genomic DNA isolated from total
thymocytes or FACS®-sorted CD4hi and CD4lo peripheral
T cells shows a clear correlation between low CD4 and
TCR expression and deleted csk loci (Fig. 2 C).
MHC-independent Positive Selection and Development of a/b
T Lineage Cells in the Absence of Csk. Are TCRloCD4lo
or TCRloCD8lo  csk-deficient cells dependent on MHC
molecules for their positive selection? To address this ques-
tion,  cskfl/fllck-cre  mice were bred onto b2m2/2Aa2/2
(MHC2) background (5, 8). The development of CD4-SP
thymocytes and CD4 T cells in cskfl/flMHC2lck-cre  mice
largely resembles that seen in cskfl/flMHC1 controls (Fig. 3
A). The development of CD8 lineage cells is unaltered
compared with cskfl/flMHC2 control mice (Fig. 3 A). De-
spite the absence of MHC molecules, thymocytes in cskfl/fl
MHC2lck-cre mice show typical signs of positive selection.
Upregulation of CD5 and CD69 on wild-type DP thy-
mocytes are the first signs of positive selection (26, 27). Ex-
pression of both markers is similarly increased in a fraction
of DP cells in cskfl/flMHC2lck-cre mice and cskfl/flMHC1
control mice, compared with the cskfl/flMHC2 control mice
(Fig. 3 B). Also, the thymocyte maturation marker CD24/
HSA is downregulated similarly in CD4-SP cells of control
and cskfl/flMHC2lck-cre mice (Fig. 3 B).
Aberrant Positive Selection of csk-deficient Thymocytes Ex-
pressing an MHC Class I–restricted Transgenic TCR. To an-
alyze in a more direct way whether the TCR can influence
the positive selection and lineage fate of csk-deficient DP
thymocytes, we introduced TCR transgenes into cskfl/fllck-
cre mice. For an MHC class II–restricted TCR transgene,
we used the DO11.10 TCR transgenic mouse strain,
which expresses the DO11.10 TCR that recognizes a
chicken ovalbumin–derived peptide in the context of I-Ad
MHC molecules (28). As expected for MHC class II–
restricted transgenic TCR, mostly CD4 T cells develop in
both control and csk-deficient mice. No obvious differ-
ences could be detected in the numbers of control and csk-
deficient thymocyte populations and peripheral T cells
(data not shown). Notably, in both thymocytes and periph-
eral CD4 T cells the expression levels of CD4 as well as the
transgenic TCR are reduced when csk deletion is achieved
Table I. Cell Numbers and Distribution of a/b T Lineage Cells in Control and csk-deficient Mice
Thymocytes DN DP CD4-SP CD8-SP Splenic  T
3106 %% %% 3106
Control 307.8 6 85.3
(n 5 5)
2.2 6 0.3
(n 5 5)
86.8 6 2.6
(n 5 5)
9.6 6 2.1
(n 5 5)
1.5 6 0.5
(n 5 5)
36.8 6 13.3
(n 5 3)
csk-deficient 312.6 6 129.9
(n 5 5)
3.6 6 1.0
(n 5 5)
77.4 6 5.7
(n 5 5)
18.3 6 5.7
(n 5 5)
0.7 6 0.1
(n 5 5)
36.7 6 13.7
(n 5 3)
Cell numbers and percentages of lymphocyte populations of control (cskfl/fl or cskfl/D) and csk-deficient (cskfl/fllck-cre or cskfl/D lck-cre) mice. No difference
was found comparing cskfl/fl and cskfl/D mice.
Figure 2. Development of TCR-bear-
ing T cells in the absence of Csk. (A) Sur-
face expression pattern of CD4 and CD8 on
thymocytes and lymph node cells isolated
from control and cskfl/fllck-cre mice, as indi-
cated. Similar data were obtained in more
than five independent experiments. (B) His-
tograms show surface expression of TCR b
on thymocyte and lymph node cell popula-
tions as gated in A. Percentage numbers in-
dicate the fraction of TCR b2 cells within
the gated population. Plain numbers indi-
cate the mean fluorescence intensity of the
gated peak. Staining controls are shown as
shaded area in all histograms. (C) Southern
blot analysis of genomic DNA isolated from
total thymocytes, non–T cells, CD4hi, or
CD4lo T cells of control and cskfl/fllck-cre
mice, as indicated. Southern blotting was
performed as described in the legend to Fig.
1. fl, loxP-flanked; D, deleted csk alleles.819 Schmedt and Tarakhovsky
by the lck-cre transgene (Fig 4, A and B). For an MHC class
I–restricted TCR transgene, we used the HY-TCR trans-
genic mouse strain. Cskfl/fllck-creHY-TCRtg mice were bred
on H-2Db or H-2Dd background. The HY-TCR is spe-
cific for the male HY antigen presented by H-2Db mole-
cules (29). In female mice, HY-TCR transgenic cells are
positively selected by an unknown peptide and only CD8
lineage T cells express both transgenic TCR a and TCR b
chains (30; Fig. 5, A and B). The analysis of positive selec-
tion of DP thymocytes in female mice expressing trans-
genic TCR and H-2Db MHC molecules reveals a strong
reduction in the percentage of CD8-SP thymocytes in the
absence of Csk compared with control HY-TCR trans-
genic mice (Fig. 5 A, top panels). At the same time, the
percentage of DP cells is reduced whereas CD4-SP and
DN cell fractions are increased about twofold. Despite re-
duced numbers of CD8-SP thymocytes in cskfl/fllck-creHY-
TCRtg mice, a sizable number of peripheral CD8 T cells
exists in these mice (Fig. 4 A). As evident from the expres-
sion of the transgenic TCR a chain on these CD8 T cells,
positive selection of CD8 T cells is not completely abro-
gated (Fig. 5 B). In normal female HY-TCR transgenic
mice, all CD4 cells express an endogenous TCR a chain
which forms an MHC class II–restricted TCR in combina-
tion with the transgenic TCR b chain (30). Therefore, the
transgenic TCR a chain is not expressed on CD4 T cells in
these mice. The analysis of surface expression of transgenic
TCR on csk-deficient CD4 T lineage cells reveals that in
contrast to control mice, a large fraction of CD4-SP thy-
mocytes and peripheral CD4 T cells express the transgenic
TCR a chain (Fig. 5 B). Similar to the phenotype of cskfl/fl
lck-cre mice, surface expression levels of CD4 and CD8 are
reduced on thymocytes and peripheral T cells of cskfl/fllck-
creHY-TCRtg mice (Fig. 5 A). Similar to the DO11.10
TCR transgene, expression from a multicopy transgenic
TCR locus does not compensate for the reduction of ex-
Figure 3. MHC-independent positive selection of csk-deficient CD4 T
cells. (A) FACS® analysis of CD4 and CD8 surface expression of thy-
mocytes and lymph node cells isolated from control and cskfl/flMHC2lck-
cre mice, as indicated. Numbers show percentages of live-gated cells. To-
tal thymocyte numbers were 271 6 93 3 106 (n 5 3), 353 6 95 3 106
(n 5 2), and 251 6 81 3 106 (n 5 2) for cskfl/flMHC1, cskfl/flMHC2, and
cskfl/flMHC2lck-cre mice, respectively. The number of splenic CD4 cells
were 24.3 6 10.1 3 106 (n 5 2), 4.5 6 2.6 3 106 (n 5 2), and 15.3 6
6.6 3 106 (n 5 2) for cskfl/flMHC1, cskfl/flMHC2, and cskfl/flMHC2lck-cre
mice, respectively. (B) Histograms show surface expression of thymocyte
maturation markers based on three-color FACS® analysis, as indicated.
DP (thin line) and CD4-SP (thick line) cells were gated as shown in A.
CD69 and CD5 expression levels on DP thymocytes of cskfl/flMHC2 mice
are shown as dotted line for reference. Staining controls are shown as
shaded area in all histograms.
Figure 4. Development of csk-deficient thymocytes expressing an
MHC class II–restricted transgenic TCR. (A) FACS® analysis of CD4 and
CD8 surface expression on thymocytes and PBLs isolated from control
cskfl/flDO11.10-TCRtg (left) and cskfl/fllck-cre DO11.10-TCRtg mice (right)
expressing I-Ad. Numbers show percentages of live-gated cells. Total cell
numbers of thymi are depicted at the top. (B) Overlay histograms show
surface expression of the transgenic TCR chain, as detected with the
KJ1.26 antibody on thymocyte and PBL populations as indicated. DN,
DP, CD4-SP, and CD4 cells were gated as shown in A on cskfl/flDO11.10-
TCRtg (thin line) or cskfl/fllck-cre DO11.10-TCRtg mice (thick line). Simi-
lar results were obtained in two independent experiments.820 Autonomous T Cell Maturation in the Absence of Csk
pression of transgenic TCR a and b chains both on thy-
mocytes and peripheral T cells of cskfl/fllck-creHY-TCRtg
mice (Fig. 5 B, and data not shown). Southern blot analysis
of the csk locus on genomic DNA of total thymocytes
shows efficient csk deletion in cskfl/fllck-creHY-TCRtg mice.
Finally, the analysis of cskfl/fllck-creHY-TCRtg mice on the
nonselecting H-2Dd background reveals that even in the
absence of the positively selecting H-2Db MHC molecules,
CD4loTCRlo cells expressing the transgenic TCR a chain
can develop (Fig. 5 D). Unlike on H-2Db background,
there is no efficient development of T3.701 CD8 T cells in
cskfl/fllck-creHY-TCRtg mice on H-2Dd background (data
not shown).
HY-TCR–mediated Negative Selection of Thymocytes Is
Functional in the Absence of Csk. The analysis of positive
selection of a/b TCR–expressing csk-deficient cells sug-
gests that selection signals originating from the expressed
TCR have little influence on the fate of csk-deficient DP
thymocytes. To test whether TCR signaling has any im-
pact at all on selection steps during thymocyte develop-
ment, we analyzed negative selection of the autoreactive
HY-TCR–expressing thymocytes in male cskfl/fllck-creHY-
TCRtg mice on H-2Db background. Similar to male con-
trol mice, thymocyte numbers are drastically reduced in
cskfl/fllck-creHY-TCRtg mice compared with female control
mice (Figs. 5 A and 6 A). Our unpublished data show that
the lck-cre transgene leads to deletion of the loxP-flanked csk
gene in up to 25% of DN thymocytes. We also found that
cre-mediated deletion of csk in 15% of DN is sufficient to
generate a full-sized thymus in TCR b or rag-1–deficient
mice (18; Fig. 1). If negative selection would be defective
in csk-deficient thymocytes, the small fraction of csk-defi-
cient cells detected by Southern blot analysis in total thy-
mocytes of cskfl/fllck-creHY-TCRtg mice (Fig. 5 B) should
give rise to thymocyte populations similar to those ob-
served in cskfl/flrag-12/2MX-cre mice (Fig. 1). As no increase
in thymocyte numbers or percentages of DP and SP cell
populations occurs in male cskfl/fllck-creHY-TCRtg mice,
negative selection in the HY-TCR system functions nor-
mally in the absence of Csk.
The Development of csk-deficient T Lineage Cells Depends on
Lck and Fyn. The interpretation of changes in T cell de-
velopment in csk-deficient mice rests on the assumption that
the negative role of Csk in the regulation of Src family
PTKs activity is the main reason for the observed pheno-
types. We have shown previously that the specific activities
of Lck and Fyn are increased in thymocytes isolated from
cskfl/flTCRb2/2MX-cre mice (18). We first tested whether
the activation of Fyn caused by the deletion of csk could
improve thymocyte development in lck-deficient mice,
which have strongly reduced thymocyte numbers and im-
paired positive selection into CD4-SP and CD8-SP cells.
When cskfl/fllck-cre mice were crossed onto an lck2/2 back-
ground, a moderate twofold increase of thymus cellularity
Figure 5. Aberrant positive selection of csk-deficient thymocytes expressing an MHC class I–restricted transgenic TCR. (A) FACS® analysis of CD4 and
CD8 surface expression on thymocytes and lymph node cells isolated from female control cskfl/flHY-TCRtg (left) and cskfl/fllck-cre HY-TCRtg mice (right)
expressing H-2Db. Numbers show percentages of live-gated cells. Total thymocyte and splenic (Spl) T cell numbers are depicted at the top. (B) Overlay
histograms show surface expression of the transgenic TCR a chain, as detected with the T3.70 antibody on thymocyte and lymph node cell populations
of cskfl/flHY-TCRtg mice (shaded area) or cskfl/fllck-cre HY-TCRtg mice (thick line) on H-2Db background, as indicated. CD8-SP, CD4-SP, CD8, and CD4
cells were gated as shown in A. The numbers of T3.701 CD4 T cells were 0.14 3 106 and 2.51 3 106 for cskfl/flHY-TCRtg and cskfl/fllck-cre HY-TCRtg
mice, respectively. Data are representative of five experiments. (C) Southern blot analysis of genomic DNA isolated from total thymocytes of control and
cskfl/fllck-cre HY-TCRtg mice on H-2Db background, as indicated. Southern blotting was performed as described in the legend to Fig. 1. fl, loxP-flanked; D,
deleted csk alleles. (D) Overlay histograms showing TCR a chain expression on thymocytes (CD4-SP) and T cells (CD4) of cskfl/flHY-TCRtg mice
(shaded area) or cskfl/fllck-cre HY-TCRtg mice (thick line) on H-2Dd background. Thymocyte numbers were 68 3 106 and 73 3 106 for cskfl/flHY-TCRtg
and cskfl/fllck-cre HY-TCRtg mice, respectively. The numbers of T3.701 CD4 T cells were 0.07 3 106 and 0.56 3 106 for cskfl/flHY-TCRtg and cskfl/fllck-cre
HY-TCRtg mice, respectively. Similar results were obtained in two independent experiments.821 Schmedt and Tarakhovsky
was apparent compared with lck2/2 mice. However, thymi
of cskfl/fllck2/2lck-cre mice were still five to sixfold smaller
than csk-deficient and control thymi (Fig. 7 A). Notably, a
small number of CD4-SP thymocytes and CD4 T cells with
reduced expression levels of CD4 and TCR could develop
in cskfl/fllck2/2lck-cre mice (Fig. 7 A). These data support the
notion that the activation of Fyn is responsible for the in-
complete block in thymocyte development of lck2/2 mice
(14). However, with respect to the TCR-independent de-
velopment of csk-deficient T lineage cells, there is no formal
proof that not other substrates of Csk could be responsible
for that phenotype. To address this question we bred cskfl/fl
lck-cre mice onto a fyn2/2lck2/2 background (13, 14, 31,
32). We then analyzed whether the autonomous develop-
ment of csk-deficient T cells could still occur in cskfl/flfyn2/2
lck2/2lck-cre mice after deletion of csk in DN thymocytes
mediated by the lck-cre transgene. The absence of both Fyn
and Lck normally causes the arrest of thymocyte develop-
ment early at the DN stage, and the analysis of thymocytes
from cskfl/flfyn2/2lck2/2lck-cre mice revealed no increase in
thymus cellularity and a block at the CD251CD442 stage
of thymocyte development similar to control cskfl/flfyn2/2
lck2/2 mice (Fig. 7 B). Southern blot analysis of total thy-
mocytes shows that csk deletion occurred in a small fraction
of the mostly DN cells of cskfl/flfyn2/2lck2/2lck-cre mice (data
not shown). Given that the lck-cre transgene leads to the de-
velopment of TCR-deficient cells after deletion of csk in
DN thymocytes, the lack of csk-deficient T lineage cells in
cskfl/flfyn2/2lck2/2lck-cre mice shows that Csk substrates or
interacting proteins other than Lck and Fyn are not by
themselves sufficient to cause the TCR-independent devel-
opment of T lineage cells in the absence of Csk.
Discussion
We used the conditional inactivation of csk in T lineage
cells to address the question whether the activation of Src
family PTKs Lck and Fyn is sufficient to support all steps in
a/b T cell development that are normally controlled by
pre-TCR or TCR engagement. It was of particular interest
to understand if engagement of the a/b TCR can influ-
ence the fate of csk-deficient thymocytes, which in princi-
ple can also develop in the complete absence of TCR mol-
ecules.
The phenotype caused by conditional csk deletion in rag-
1–deficient mice shows that TCR2 T lineage cells, as evi-
dent by CD90/Thy-1 and CD5 expression, can develop in
the absence of Csk (Fig. 1). This phenotype is similar to the
previously reported pre-TCR, a/b TCR–independent de-
velopment of a/b T lineage cells in cskfl/flTCRb2/2MX-cre
mice (18). Therefore, the possibility of any critical contri-
bution from the g/d TCR to the a/b TCR–independent
development of a/b T lineage cells in the absence of Csk
can be excluded.
Based on the lack of a/b T cell development of cskfl/fl
fyn2/2lck2/2lck-cre mice, it can also be excluded that Csk
substrates or interacting proteins other than Lck and Fyn
are sufficient for the autonomous T cell development in
the absence of Csk (Fig. 6). Lck and Fyn are absolutely re-
quired for the development of thymocytes past the
CD251CD442 DN stage, even in the absence of Csk. This
does not exclude that Csk may regulate other proteins or
may have additional functions earlier in T cell development
before the proximal lck promoter becomes active (33, 34).
Given that the TCR is dispensable for T cell develop-
ment in the absence of Csk, we wanted to understand
whether engagement of the TCR or coreceptors on csk-
deficient thymocytes influences their developmental fate.
Using cskfl/fl mice in combination with the lck-cre transgene,
we could analyze the development of csk-deficient thy-
mocytes in the presence of the TCR. Similar to cskfl/fl
TCRb2/2MX-cre mice and cskfl/flrag-12/2MX-cre mice, the
number of CD8 T cells is reduced both in the thymus and
in peripheral lymphoid organs of cskfl/fllck-cre mice, whereas
the number of CD4-SP thymocytes is consistently in-
creased in the absence of Csk compared with controls
(Figs. 1 A and 2 A). This bias for commitment to the CD4
T lineage could be the result of increased or extended ac-
tivity of Lck and Fyn in the absence of Csk. Indeed, we
have shown previously that the specific activity of Lck and
Figure 6. Normal negative selection of csk-deficient thymocytes expressing an MHC class I–restricted transgenic TCR. (A) FACS® analysis of CD4, CD8,
and T3.70 surface expression on thymocytes isolated from male cskfl/flHY-TCRtg and cskfl/fllck-cre HY-TCRtg mice on H-2Db background. Dot plots show
T3.701 thymocytes, gated as indicated in the histogram insert. Total cell numbers of thymi (Thy) are shown at the top. Data are representative of three inde-
pendent experiments. (B) Southern blot analysis of genomic DNA isolated from total thymocytes of two male control and two male cskfl/flHY-TCRlck-cre
mice on H-2Db background, as indicated. Southern blotting was performed as described in the legend to Fig. 1. fl, loxP-flanked; D, deleted csk alleles.822 Autonomous T Cell Maturation in the Absence of Csk
Fyn are increased in csk-deficient thymocytes (18). This
could be interpreted by the cell as a strong TCR-derived
signal, which according to various recent reports favors de-
velopment of CD4 lineage cells (35–39).
Development of CD4 T cells in the absence of Csk can
occur without TCR/MHC interaction. Three indepen-
dent results of our experiments support this conclusion.
First, TCR-deficient T cells are present in csk-deficient rag-
12/2 or TCR b2/2 mice (reference 1; Fig. 1). Second,
TCR-expressing T cells develop in the absence of MHC
class I and MHC class II (Fig. 3). And third, transgenic
TCR-expressing T cells develop in the absence of the pos-
itively selecting MHC molecule (Fig. 5 B). Despite the in-
dependence of TCR/MHC interaction, in all of these
cases, the typical changes in the expression of thymocyte
maturation markers (CD69, CD5, and CD24/HSA) that
normally accompany positive selection are observed (Figs.
1 and 3, and data not shown). It is intriguing that even in
the absence of TCR engagement, CD69 and CD5 matura-
tion markers are expressed on a similar fraction of DP cells,
as in controls. This could indicate that the deletion of csk
initiates a predetermined developmental program that in-
cludes the changes in maturation marker expression at the
appropriate time. Alternatively, after the deletion of csk in
DP thymocytes, a gradual decline of Csk protein levels
reaches thresholds at which Lck and Fyn become activated
only in a small fraction of cells at a given time. This activa-
tion of Lck and Fyn may mimic a “true” TCR-derived sig-
nal and lead to the changes in maturation marker expres-
sion.
We investigated directly whether engagement of the
TCR influences the development of csk-deficient thy-
mocytes by the analysis of development of T cells express-
ing a transgenic TCR. Although development of TCR
transgenic thymocytes in an MHC class II–restricted
DO11.10 system appears largely normal in the absence of
Csk, the MHC class I–restricted HY-TCR system showed
very unusual features. Similar to the situation in nontrans-
genic  csk-deficient mice, positive selection in cskfl/fllck-
creHY-TCRtg mice produces mostly CD4-SP thymocytes
Figure 7. Development of csk-deficient T lineage cells is dependent on
the presence of Lck and Fyn. (A) FACS® analysis of surface expression of
CD4 and CD8 on thymocytes and lymph node cells isolated from various
control and cskfl/fllck2/2lck-cre mice, as indicated. Numbers show percent-
ages of live-gated cells. The total thymocyte (Thy) and splenic T cell num-
bers are indicated at the top. (B) FACS® analysis of surface expression of
CD4, CD8, CD25, and CD44 on thymocytes isolated from control and
cskfl/fllck2/2fyn2/2lck-cre mice, as indicated. The bottom panel shows CD25
vs. CD44 surface expression on DN cells gated as shown in the top panels.
Numbers show percentages of live-gated cells. Similar numbers of dots are
shown in the bottom panel. Total thymocyte numbers are depicted at the
top. Similar results were obtained in three independent experiments.823 Schmedt and Tarakhovsky
in contrast to the cskfl/flHY-TCRtg controls. Also different
from control mice, the csk-deficient CD4-SP as well as pe-
ripheral CD4 cells in cskfl/fllck-creHY-TCRtg mice express
both the transgenic TCR a and b chains (Fig. 4 B). Posi-
tive selection of these unusual CD4 lineage cells is unlikely
mediated by their MHC class I–restricted transgenic TCR,
but rather appears to be uncoupled from TCR engagement
as seen for example in cskfl/flMHC2lck-cre mice (Fig. 3).
This interpretation is consistent with the recently published
ability of activated Lck to redirect the positive selection of
thymocytes expressing a different MHC class I–restricted
TCR transgene from the CD8 into the CD4 lineage (38).
Notably, in that study a TCR transgene was used that can
function independently of the CD8 coreceptor. Thus, pos-
itive selection and commitment to the CD4 lineage by ac-
tivated Lck may also be TCR and MHC independent, as in
the absence of Csk.
Despite the apparent uncoupling of TCR engagement
and positive selection into the CD4 T lineage, two results
of the analysis of cskfl/fllck-creHY-TCRtg mice point to the
fact that signals derived from the TCR of csk-deficient thy-
mocytes can influence their developmental fate. First, CD8
T cells bearing the transgenic TCR do develop in cskfl/fllck-
creHY-TCRtg mice. This occurs at reduced efficiency com-
pared with cskfl/flHY-TCRtg control mice; however, the
frequency of TCR transgenic csk-deficient CD8 T cells is
significantly higher than that of CD8 T cells in cskfl/fllck-cre
mice (compare Fig. 5, A and B, and Fig. 2 A). Therefore,
appropriate positive selection of csk-deficient thymocytes
into the correct T cell lineage can occur, albeit at reduced
efficiency. Second, the analysis of male cskfl/fllck-creHY-
TCRtg mice on H-2Db MHC background males clearly
shows that TCR-mediated negative selection in the HY-
TCR system in csk-deficient thymocytes is not impaired
(Fig. 5). The reduced number of HY-TCR expressing
CD8-SP thymocytes in female cskfl/fllck-creHY-TCRtg mice
on H-2Db MHC background may result from a deviation
of positive selection into the CD4 T lineage due to stron-
ger TCR-derived signal in the absence of Csk. Further
analysis of thymocyte development in the absence of Csk
in different TCR transgenic systems is required to confirm
the differential role of Csk-mediated regulation of Lck and
Fyn in positive and negative selection.
The surface expression of TCR as well as CD4 and CD8
coreceptors is significantly reduced on csk-deficient com-
pared with control thymocytes and peripheral T cells. This
phenotype is observed in all mice analyzed in this study, in-
cluding those expressing a transgene-encoded TCR. The
correlation between low receptor expression levels and csk
deficiency is established by Southern blot analysis of CD4lo
and CD4hi cells (Fig. 2 C). Reduction of TCR expression
levels in the absence of Csk could be the consequence of
Lck activation in these cells. On mature T cells, the ligation
of TCR by MHC/peptide ligands and presumable activa-
tion of Lck leads to the endocytosis and lysosomal degrada-
tion of TCRs (40). Also, expression of the constitutively
active Tyr505Phe mutant of Lck in mature T cells causes
downregulation of surface TCR and degradation in a lyso-
somal compartment (41). Mice expressing a transgenic
TCR and constitutively active Lck transgene show reduced
TCR surface expression on thymocytes compared with
only TCR transgenic control mice (42). Little is known
about the regulation of CD4 and CD8 surface expression.
However, both positive selection of DP thymocytes, which
presumably activates Src family PTKs, and stimulation of
mature T cells is accompanied by the reduction of corecep-
tor surface expression (43–46). Downregulation of TCR
and coreceptors may also in some way be coordinated;
however, the low expression level of CD4 on TCR-defi-
cient T lineage cells in cskfl/flTCRb2/2MX-cre and cskfl/flrag-
12/2MX-cre mice argues against a tight coordination.
The reduced TCR and coreceptor expression levels seen
in the absence of csk do not impair the function of mature
T cells as defined by analysis of Ca21 flux and proliferation
in response to TCR cross-linking (data not shown, unpub-
lished observations). It remains to be shown whether the
reduced TCR and coreceptor expression levels represent a
cell autonomous adaptation to the defective regulation of
Lck- and Fyn-mediated signaling from the TCR and core-
ceptors.
In conclusion, our data show that the Csk-mediated reg-
ulation of Lck and Fyn during T cell development is essen-
tial for the establishment of developmental checkpoints that
require signals from the pre-TCR and TCR to be faith-
fully transmitted to the developing thymocyte. It remains
to be addressed whether the csk-deficient T cells populating
peripheral lymphoid organs are dependent on TCR-medi-
ated survival signals.
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